Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis

Milena Paw,Agnieszka A. Kusiak,Kinga Nit,Jacek J. Litewka,Marcin Piejko,Dawid Wnuk,Michał Sarna,Kinga Fic,Kinga B. Stopa,Ruba Hammad,Olga Barczyk-Woznicka,Toni Cathomen,Ewa Zuba-Surma,Zbigniew Madeja,Paweł E. Ferdek,Sylwia Bobis-Wozowicz
DOI: https://doi.org/10.1186/s12916-023-03117-w
IF: 9.3
2023-11-02
BMC Medicine
Abstract:Cardiac fibrosis is one of the top killers among fibrotic diseases and continues to be a global unaddressed health problem. The lack of effective treatment combined with the considerable socioeconomic burden highlights the urgent need for innovative therapeutic options. Here, we evaluated the anti-fibrotic properties of extracellular vesicles (EVs) derived from human induced pluripotent stem cells (hiPSCs) that were cultured under various oxygen concentrations.
medicine, general & internal
What problem does this paper attempt to address?